Effect of polyunsaturated fatty acids on doxorubicin cytotoxicity in glioma cells in vitro

Advances in Clinical and Experimental Medicine

Volumn 19, Issue 4, 2010, Pages 481-487

  Zajdel, Alicja ^a   Wilczok, Adam ^a   Latocha, Małgorzata ^a   Dzierzewicz, Zofia ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Doxorubicin; Glioma cells; Polyunsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOXORUBICIN; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; POLYUNSATURATED FATTY ACID; TETRAZOLIUM;

ARTICLE; CELL GROWTH; CELL VIABILITY; CYTOTOXICITY; DRUG EFFECT; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; SKIN FIBROBLAST; TUMOR GROWTH;

EID: 77957320068     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Eynard AR: Potential of essential fatty acids as natural therapeutic products for human tumors. Nutrition 2003, 19, 386-387.
2. Benatti P, Peluso G, Nicolai R, Calvani M: Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr 2004, 23, 281-302. (Pubitemid 39096388)
3. Das UN: Gamma-linolenic acid therapy of human glioma - a review of in vitro, in vivo, and clinical studies. Med Sci Monit 2007, 13, 119-131.
4. Miyake JA, Benadiba M, Colquhoun A: Gamma-linolenic acid inhibits both tumour cell cycle progression and angiogenesis in the orthotopic C6 glioma model through changes in VEGF, Flt1, ERK1/2, MMP2, cyclin DI, pRb, p53 and p27 protein expression. Lipids Health Dis 2009, 8, 8.
5. Das UN: Tumoricidal and anti-angiogenic actions of gamma-linolenic acid and its derivatives. Curr Pharm Biotechnol 2006, 7, 457-466.
6. Vartak S, Robbins ME, Spector AA: Polyunsaturated fatty acids increase the sensitivity of 36B10 rat astrocytoma cells to radiation-induced cell kill. Lipids 1997, 32, 283-292.
7. Rudra PK, Krokan HE: Cell specific enhancement of doxorubicin toxicity in human tumor cells by docosa-hexaenoic acid. Anticancer Res 2001, 21, 29-38.
8. Das UN, Madhavi N, Sravan Kumar G, Padma M, Sangeetha P: Can tumor cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukot Essent Fatty Acids 1998, 58, 39-54.
9. Mahéo K, Vibet S, Steghens JP, Dartigeas C, Lehman M, Bougnoux P, Goré J: Differential sensitization of cancer cells to doxorubicin by DHA: A role for lipoperoxidation. Free Radic Biol Med 2005, 39, 742-751.
10. Hansen-Petrik MB, McEntee MF, Johnson BT, Obukowicz G, Masferrer J, Zweifel B, Chiu CH, Whelan J: Selective inhibition of Δ-6 desaturase impedes intestinal tumorigenesis. Cancer Lett 2002, 175, 157-163.
11. Berquin IM, Edwards IJ, Chen YQ: Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 2008, 269, 363-377.
12. Youdim KA, Martin A, Joseph JA: Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci 2000, 18, 383-399. (Pubitemid 30244351)
13. Leaver HA, Wharton SB, Bell HS, Leaver-Yap IM, Whittle IR: Highly unsaturated fatty acid induced tumour regression in glioma pharmacodynamics and bioavailability of gamma linolenic acid in an implantation glioma model: effects on tumour biomass, apoptosis and neuronal tissue histology. Prostaglandins Leukot Essent Fatty Acids 2002, 67, 283-292.
14. Leaver HA, Bell HS, Rizzo MT, Ironside JW, Gregor A, Wharton SB, Whittle IR: Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma. Prostaglandins Leukot Essent Fatty Acids 2002, 66,19-29.
15. Leaver HA, Williams JR, Smith C, Whittle IR: Intracellular oxidation by human glioma cell populations: effect of arachidonic acid. Prostaglandins Leukot Essent Fatty Acids 2004, 70, 449-53. (Pubitemid 38482606)
16. Leonardi F, Attorri L, Benedetto RD, Biase AD, Sanchez M, Tregno FP, Nardini M, Salvati S: Docosahexaenoic acid supplementation induces dose and time dependent oxidative changes in C6 glioma cells. Free Radic Res 2007, 41, 748-756. (Pubitemid 46995256)
17. Nasrollahzadeh J, Siassi F, Doosti M, Eshraghian MR, Shokri F, Modarressi MH, Mohammadi-Asl J, Abdi K, Nikmanesh A, Karimian SM: The influence of feeding linoleic, gamma-linolenic and docosahexaenoic acid rich oils on rat brain tumor fatty acids composition and fatty acid binding protein 7 mRNA expression. Lipids Health Dis 2008, 7, 45.
18. Pardini RS: Nutritional intervention with omega-3 fatty acids enhances tumor response to anti-neoplastic agents. Chem Biol Interact 2006, 162, 89-105.
19. Leonardi F, Attorri L, Di Benedetto R, Di Biase A, Sanchez M, Nardini M, Salvati S: Effect of arachidonic, eicosapentaenoic and docosahexaenoic acids on the oxidative status of C6 glioma cells. Free Radic Res 2005, 8, 865-874. (Pubitemid 40975080)
20. Williams JR, Leaver HA, Ironside JW, Miller EP, Whittle IR, Gregor A: Apoptosis in human primary brain tumours: actions of arachidonic acid. Prostaglandins Leukot Essent Fatty Acids 1998, 58, 193-200.
21. Kokoglu E, Tuter Y, Yazici Z, Sandikci KS, Sonmez H, Ulakoglu EZ, Ozyurt E: Profiles of the fatty acids in the plasma membrane of human brain tumors. Cancer Biochem Biophys 1998, 16, 301-312.
22. Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, Spencer D, Berry D, Steward W, Dennison A: The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer 2009, 45, 2077-2086.
23. Ramos KL, Colquhoun A: Protective role of glucose-6-phosphate dehydrogenase activity in the metabolic response of C6 rat glioma cells to polyunsaturated fatty acid exposure. Glia 2003, 43, 149-166.
24. Chung FL, Pan J, Choudhury S, Roy R, Hu W, Tang MS: Formation of trans-4-hydroxy-2-nonenal- and other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation. Mutat Res 2003, 531, 25-36. (Pubitemid 37456722)
25. Siddiqui RA, Harvey K, Stillwell W: Anticancer properties of oxidation products of docosahexaenoic acid. Chem Phys Lipids 2008, 153, 47-56.
26. Farin A, Suzuki SO, Weiker M, Goldman JE, Bruce JN, Canoll P: Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia 2006, 53, 799-808.
27. Ito K, Abe T, Tomita M, Morimoto A, Kohno K, Mori T, Ono M, Sugenoya A, Nishihira T, Kuwano M: Antiangiogenic activity of arachidonic acid metabolism inhibitors in angiogensis model systems involving human microvascular endothelial cells and neovascularization in mice. Int J Cancer 1993, 55, 660-666.